Penserra Capital Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Penserra Capital Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-875	Closed	-$103K	–	1444
2021 Q1	$103K	Sell	875 -15	-2%	-$1.77K	﹤0.01%	679
2020 Q4	$105K	Buy	890 +562	+171%	+$65.3K	﹤0.01%	597
2020 Q3	$36K	Buy	+328	New	+$35.2K	﹤0.01%	667
2017 Q1	–	Sell	-268	Closed	-$28K	–	944
2016 Q4	$28K	Buy	+268	New	+$31.3K	﹤0.01%	460
2016 Q2	–	Sell	-300	Closed	-$34	–	1028
2016 Q1	$34	Hold	300	–	–	﹤0.01%	358
2015 Q4	$43K	Buy	+300	New	+$34.6K	﹤0.01%	270

Penserra Capital Management's CBPO Position: Q2 2021 in Review

Penserra Capital Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 875 shares — an estimated $103K sold.

Penserra Capital Management first reported a position in CBPO in Q4 2015 and held it in 6 quarters. The position peaked at $105K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Penserra Capital Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Penserra Capital Management sold 875 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $103K.
Penserra Capital Management first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 6 quarters.
Penserra Capital Management's China Biologic Products Holdings, Inc. position peaked at $105K in Q4 2020.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Penserra Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.